Testing a new albuterol inhaler for mild asthma
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests if a new albuterol inhaler works as well as the standard one for people with mild asthma. You'll breathe in a medicine that measures how your lungs respond, helping show the new inhaler is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with mild asthma by a doctor at least 6 months ago
- You have not smoked in the last 6 months and have a limited smoking history
- You have not had a respiratory infection (like a cold, flu, or pneumonia) in the past 6 weeks
- If female, you are not pregnant or breastfeeding and willing to use birth control
- Your lung function (FEV1) is at least 80% of normal and can be measured reliably
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks whether a new albuterol inhaler works the same way as a reference inhaler in adults with stable, mild asthma. It may help you (and others) by confirming that the inhaler delivers the right effect and is safe to use.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This trial tests whether a new inhaler (CHF5993) works as well as the current standard for adults with mild to moderate asthma. It compares how well the medicine controls asthma and opens airways.
This trial tests if a new combination inhaler (formoterol/fluticasone) works as well as an existing one (Alenia) for people with moderate asthma. You may be able to join if your asthma is stable and well controlled with your current treatment.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
This study tests a new combination inhaler (budesonide/albuterol) against another asthma inhaler in adults whose asthma is not well controlled on their current medications. It aims to see if the new inhaler can reduce serious asthma attacks and improve symptoms.
Hear when a new Mild Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.